Reports
Reports
Sale
The global home healthcare market attained a value of USD 307 billion in 2023. The market is anticipated to grow at a CAGR of 8.26% during the forecast period of 2024-2032 to attain a value of USD 627.2 billion by 2032. The market growth is driven by the increasing incidence of chronic diseases across the globe.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Home healthcare involves providing healthcare services to vulnerable individuals so that they can be treated in the comfort of their homes. It includes various services provided by skilled and unskilled healthcare professionals such as elder care services, and pregnancy care services, among others. Home healthcare may be short-term or long-term depending upon the needs of the patient and can involve the use of specialised tools and equipment.
The global homecare market requires a variety of equipment, depending upon the specific needs of the patient and the type of care. While certain products are used for monitoring purposes, others are used for treatment, and for the prevention of complications. Long-term usage equipment for the treatment of chronic conditions occupies a significant share of the market, with types of equipment comprising insulin delivery devices, inhalers, nebulisers, and sleep apnea therapeutic devices.
The newer technologies in this market have improved the communication flow between patients and healthcare providers, enabling better, faster, and more effective care. The increase in the prevalence of chronic conditions, growing awareness of lifestyle diseases, and the rise in elderly suffering from long-term health diseases will therefore increase the demand for home healthcare, proving favourable for market growth.
Increasing Incidence of Research and Development Activities
Asthma is a major noncommunicable disease (NCD), affecting both children and adults, and is the most common chronic disease among children affecting more than 262 million people and causing 455,000 deaths. The increasing prevalence is calling for innovations and a sufficient supply-demand chain so that a maximum number of patients can avail of asthma therapeutics. To fill this crucial gap of unmet needs, researchers are trying to develop more effective and innovative inhalers for asthma patients. This initiative from the FDA and the practice by researchers is expected to propel the home healthcare industry growth. For instance, the US Food and Drug Administration (FDA) awarded a group of Australian researchers USD 687,000 to develop improved testing methods for dry powder inhalers. This project is expected to enable more effective development of inhalers, specifically generic inhaler devices. These developments are being performed to increase access to affordable inhalers for asthma patients in the United States and across the globe.
Investment Activities Expected to Propel Development in the Market
The homecare market is experiencing a significant trend toward developing monitoring equipment and technologies to diagnose and keep track of patient’s health activities with certain medical conditions. Medical disorders such as sleep apnea are among those that require continuous monitoring through specific monitoring devices. Huge amount of fundings are required to perform these developments that support the research and development procedure, further contributing to market growth. For instance, in December 2023, Aesyra, a medical device company developing oral appliance technologies to improve sleep, raised USD 3 million in seed financing to support the development and commercialization of the AesyBite line of products for accurate monitoring and treatment of sleep bruxism and sleep apnea.
Strategic Collaborations to Aid Market Growth During the Forecast Period
The home healthcare industry size is poised to grow significantly during the forecast period driven by strategic collaborations and partnerships between market key players. Such strategic moves by the companies are a major factor expected to bring innovation in the market development and propel the global home healthcare market growth.
The market is witnessing several trends and developments to improve the current global scenario. Some of the notable trends are as follows:
Increasing Geriatric Population
The rising geriatric population worldwide and the increasing prevalence of chronic diseases influence the market. The increasing requirement for chronic disease management programs for the older population is triggering the market.
Technological Advancements to Offer Improved Solutions
The home healthcare industry is witnessing rapid technological advancements contributing to market growth. The integration and adoption of telehealth and increasing usage of wearables and remote monitoring devices are further contributing to market growth.
Preference for Cost Effective Devices
The market is witnessing increased adoption of home healthcare as compared to hospital care, home healthcare is much more cost-effective hence, responsible for increased adoption by both patients and healthcare professionals.
One of the common devices used regularly in home healthcare settings is a pulse oximeter, a device that oxygen saturation levels without using needles or fetching a blood sample. Innovation in such technologies is anticipated to boost the market demand during the forecast period. For instance, in November 2023, GE HealthCare and Masimo announced a joint agreement to join Masimo Signal Extraction Technology® (SET®) pulse oximetry into GE HealthCare’s Portrait Mobile wireless and wearable patient monitoring solution. Portrait Mobile is an Internet of Medical Things (IoMT) platform, that provides an end-to-end experience for wearable continuous monitoring by using the latest cloud-native technology. By integrating Masimo SET®, clinicians will be able to leverage Masimo’s clinically proven Measure-through Motion and Low Perfusion™ oxygen saturation (SpO2) measurement technology to noninvasively detect and continuously monitor changes in patient status.
In December 2023, Medtronic, a leading healthcare technology company, announced that it was expanding its partnership with Cosmo Intelligent Medical Devices (a subsidiary of Cosmo Pharmaceuticals). This partnership was intended to strengthen Medtronic's position in the field of AI-integrated healthcare solutions and mark significant advancements by incorporating artificial intelligence into endoscopic care. The collaboration focused on innovative and scalable AI platforms like AI Access™, which is designed to host multiple third-party AI applications, allowing for faster innovation and streamlining of the AI development process across medical AI applications. This approach to healthcare represents a new and innovative way of thinking and will enable a broader spectrum of diagnostic tools and treatment options which may further come down to the home healthcare diagnostics.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
Market Breakup by Product
Market Breakup by Application
Market Breakup by Region
Market Segmentation by Product Type is Expected to Experience Substantial Growth
The market segmentation by product is broadly divided into therapeutic products, diagnostic and monitoring products, mobility care devices and services among others. Therapeutic products such as dialysis equipment, wound care products, IV equipment, sleep apnea therapeutic devices, insulin delivery devices, inhalers, and others are used to treat chronic conditions in patients. The therapeutic product segment holds a significant home healthcare market share. Diagnostic and monitoring products are further segmented into blood glucose monitors, hearing aids, blood pressure monitors, temperature monitoring devices, ovulation and pregnancy test kits, pulse oximeters, drug and alcohol test kits, home sleep testing devices, cholesterol testing products, and home hemoglobin A1C test kits.
Skilled nursing services, rehabilitation therapy services, hospice and palliative care services, unskilled care services, respiratory therapy services, infusion therapy services, pregnancy care services are amongst services included in the home healthcare market. Lastly, the market segmentation by product involves mobility care products such as wheelchairs, mobility scooters, walkers and rollators, crutches, and others. Products such as wheelchairs and mobility scooters play a crucial role for patients with limited to no movements in the body as they enable the patient to move from one place to another with less effort.
Cancer Holds a Significant Share of the Application Segment
Based on the home healthcare market report, the market segment by application includes cancer, respiratory disease, movement disorders, CVD & hypertension, pregnancy, wound care, diabetes, and hearing disorders, among others. Cancer accounts for a considerable market share due to the rising geriatric population and increasing prevalence of cancer. In 2022, approximately 20 million new cancer cases emerged according to the World Health Organization. Nearly 1 in 5 people suffer from cancer at least once in a lifetime. Lung cancer was the most common cancer globally with 2.5 million new cases. Other diseases such as diabetes, hypertension and cardiovascular diseases are expected to account for a substantial market share. This can be attributed to increasing prevalence of the condition due to sedentary lifestyle, and unhealthy dietary habits.
Read more about this report - REQUEST FREE SAMPLE COPY IN PDF
The market report offers an insight into various demographical regions, including North America, Europe, Asia-Pacific, Latin America as well as Middle East and Africa. The regional development and penetration of the home healthcare market depend heavily upon market maturity, awareness of the public, support from healthcare providers, and level of expense. North America heavily invests in the home healthcare sector and is a major leading region in the market for home healthcare. The large geriatric population, high volume of chronic diseases, and expensive hospital stays encourage spending on home healthcare. Due to the increased chronic conditions, regular monitoring of health is advised by healthcare professionals. Hence, the U.S. home healthcare market size is expected to expand in the forecast period.
Europe closely follows with countries like Germany, France, and the United Kingdom leading due to robust healthcare infrastructure and supportive government policies. The home healthcare market in Europe is poised to expand due to the increasing innovation and integration of advanced technologies in the home healthcare domain. For instance, in April 2024, Health Tech Solutions Group (HTS), a legendary healthcare provider decided to expand and improve access to healthcare services in the United Kingdom. HTS provides healthcare solutions including mobile health services. HTS’s further plans involve raising GBP 3 million in investment to expand to more locations in the UK and Ireland by 2025 .
In the Middle East, the home healthcare market UAE is emerging due to the heightened awareness about the benefits of home healthcare. With strategic investments in healthcare infrastructure, coupled with government initiatives to promote advanced healthcare services, the region is positioned as a key player in the region. The regional market growth can be attributed to the increasing adoption of telemedicine and remote monitoring solutions. With a surge in financial support from investors, the market is expected to experience an upward trajectory.
The key features of the market report include patent analysis, and strategic initiatives by the leading key players. The major companies in the market are as follows:
Fresenius Medical Care
It was founded in 1996 and is headquartered in Bad Homburg, Germany. It specialises in products and services for people with chronic kidney failure. The company's portfolio includes dialysis machines, dialysers, and related disposable products, as well as comprehensive dialysis care services through a global network of clinics. In February 2024, the company announced the U.S. Food and Drug Administration (FDA) 510(k) clearance for the 5008X Hemodialysis System, augmenting the improved home healthcare services market.
Medtronic Plc
Medtronic Plc, founded in 1949, is headquartered in Dublin, Ireland. It is a global leader in medical technology, offering a broad range of products. Key portfolio items include cardiac devices, insulin pumps, spinal and neurosurgery products, and advanced surgical tools, aimed at treating chronic diseases and improving patient outcomes. In August 2022, Medtronic strategically partnered with BioIntelliSense, a continuous health monitoring and clinical intelligence company. This partnership aims to set a new level of surveillance and workflow efficiencies in hospitals and remote hospital settings including home healthcare.
3M Company
3M Company is a division of 3M which was established in 1902 and is headquartered in St. Paul, Minnesota. The company offers innovative medical solutions across various categories. The main products include wound care, infection prevention, dental products, and health information systems, supporting healthcare providers in delivering quality patient care.
Other key players in the market include Becton, Dickinson and Company, Abbott, B Braun Melsungen AG, Arkray, Inc., F Hoffmann La Roche AG, ConvaTech Group PLC, GE Healthcare, Koninklijke Philips N.V., and RedMed, Inc.
REPORT FEATURES | DETAILS |
Base Year | 2023 |
Historical Period | 2017-2023 |
Forecast Period | 2024-2032 |
Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
Breakup by Product |
|
Breakup by Application |
|
Breakup by Region |
|
Market Dynamics |
|
Supplier Landscape |
|
Companies Covered |
|
Home Healthcare Market Analysis
Home Healthcare Market Regional Analysis
*While we strive to always give you current and accurate information, the numbers depicted on the website are indicative and may differ from the actual numbers in the main report. At Expert Market Research, we aim to bring you the latest insights and trends in the market. Using our analyses and forecasts, stakeholders can understand the market dynamics, navigate challenges, and capitalize on opportunities to make data-driven strategic decisions.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Home Healthcare Market Overview
3.1 Global Home Healthcare Market Historical Value (2017-2023)
3.2 Global Home Healthcare Market Forecast Value (2024-2032)
4 Vendor Positioning Analysis
4.1 Key Vendors
4.2 Prospective Leaders
4.3 Niche Leaders
4.4 Disruptors
5 Global Home Healthcare Market Landscape*
5.1 Global Home Healthcare: Developers Landscape
5.1.1 Analysis by Year of Establishment
5.1.2 Analysis by Company Size
5.1.3 Analysis by Region
5.2 Global Home Healthcare: Product Landscape
5.2.1 Analysis by Product
5.2.2 Analysis by Application
6 Global Home Healthcare Market Dynamics
6.1 Market Drivers and Constraints
6.2 SWOT Analysis
6.2.1 Strengths
6.2.2 Weaknesses
6.2.3 Opportunities
6.2.4 Threats
6.3 PESTEL Analysis
6.3.1 Political
6.3.2 Economic
6.3.3 Social
6.3.4 Technological
6.3.5 Legal
6.3.6 Environment
6.4 Porter’s Five Forces Model
6.4.1 Bargaining Power of Suppliers
6.4.2 Bargaining Power of Buyers
6.4.3 Threat of New Entrants
6.4.4 Threat of Substitutes
6.4.5 Degree of Rivalry
6.5 Key Demand Indicators
6.6 Key Price Indicators
6.7 Industry Events, Initiatives, and Trends
6.8 Value Chain Analysis
7 Global Home Healthcare Market, Epidemiology Snapshot
7.1 Overview of Global Home Healthcare Incidence Number (2017-2032)
7.2 Incidence Number, By Indication (2017-2032)
7.2.1 Cancer
7.2.2 Respiratory Disease
7.2.3 Mobility Disorders
7.2.4 CVD & Hypertension
7.2.5 Wound Care
7.2.6 Diabetes
7.2.7 Hearing Disorders
7.2.8 Others
8 Global Home Healthcare Market Segmentation (2017-2032)
8.1 Global Home Healthcare Market (2017-2032) by Product
8.1.1 Market Overview
8.1.2 Products
8.1.2.1 Therapeutic Products
8.1.2.1.1 Dialysis Equipment
8.1.2.1.2 Wound Care Products
8.1.2.1.3 IV Equipment
8.1.2.1.4 Sleep Apnea Therapeutic Devices
8.1.2.1.5 Insulin Delivery Devices
8.1.2.1.6 Oxygen Delivery Systems
8.1.2.1.7 Inhalers
8.1.2.1.8 Ventilators
8.1.2.1.9 Others
8.1.2.2 Diagnostic & Monitoring Products
8.1.2.2.1 Blood Glucose Monitors
8.1.2.2.2 Blood Pressure Monitors
8.1.2.2.3 Temperature Monitoring Device
8.1.2.2.4 Ovulation & Pregnancy Test Kits
8.1.2.2.5 Pulse Oximeters
8.1.2.2.6 Drug and Alcohol Test Kits
8.1.2.2.7 Home Sleep Testing Devices
8.1.2.2.8 Cholesterol Testing Products
8.1.2.2.9 ECG Devices
8.1.2.2.10 Home Hemoglobin A1C Test Kits
8.1.2.2.11 Others
8.1.2.3 Mobility Care Products
8.1.2.3.1 Wheelchair
8.1.2.3.2 Mobility Scooters
8.1.2.3.3 Walkers and Rollators
8.1.2.3.4 Crutches
8.1.2.3.5 Others
8.1.3 Services
8.1.3.1 Skilled Nursing Services
8.1.3.2 Rehabilitation Therapy Services
8.1.3.3 Hospice and Palliative Care Services
8.1.3.4 Respiratory Therapy Services
8.1.3.5 Infusion Therapy Services
8.1.3.6 Pregnancy Care Services
8.1.3.7 Others
8.2 Global Home Healthcare Market (2017-2032) by Application
8.2.1 Market Overview
8.2.2 Cancer
8.2.3 Respiratory Disease
8.2.4 Mobility Disorders
8.2.5 CVD & Hypertension
8.2.6 Pregnancy
8.2.7 Wound Care
8.2.8 Diabetes
8.2.9 Hearing Disorders
8.2.10 Others
8.3 Global Home Healthcare Market (2017-2032) by Region
8.3.1 Market Overview
8.3.2 North America
8.3.3 Europe
8.3.4 Asia Pacific
8.3.5 Latin America
8.3.6 Middle East and Africa
9 North America Home Healthcare Market (2017-2032)
9.1 North America Home Healthcare Market (2017-2032) by Product
9.1.1 Market Overview
9.1.2 Products
9.1.2.1 Therapeutic Products
9.1.2.1.1 Dialysis Equipment
9.1.2.1.2 Wound Care Products
9.1.2.1.3 IV Equipment
9.1.2.1.4 Sleep Apnea Therapeutic Devices
9.1.2.1.5 Insulin Delivery Devices
9.1.2.1.6 Oxygen Delivery Systems
9.1.2.1.7 Inhalers
9.1.2.1.8 Ventilators
9.1.2.1.9 Others
9.1.2.2 Diagnostic & Monitoring Products
9.1.2.2.1 Blood Glucose Monitors
9.1.2.2.2 Blood Pressure Monitors
9.1.2.2.3 Temperature Monitoring Device
9.1.2.2.4 Ovulation & Pregnancy Test Kits
9.1.2.2.5 Pulse Oximeters
9.1.2.2.6 Drug and Alcohol Test Kits
9.1.2.2.7 Home Sleep Testing Devices
9.1.2.2.8 Cholesterol Testing Products
9.1.2.2.9 ECG Devices
9.1.2.2.10 Home Hemoglobin A1C Test Kits
9.1.2.2.11 Others
9.1.2.3 Mobility Care Products
9.1.2.3.1 Wheelchair
9.1.2.3.2 Mobility Scooters
9.1.2.3.3 Walkers and Rollators
9.1.2.3.4 Crutches
9.1.2.3.5 Others
9.1.3 Services
9.1.3.1 Skilled Nursing Services
9.1.3.2 Rehabilitation Therapy Services
9.1.3.3 Hospice and Palliative Care Services
9.1.3.4 Respiratory Therapy Services
9.1.3.5 Infusion Therapy Services
9.1.3.6 Pregnancy Care Services
9.1.3.7 Others
9.2 North America Home Healthcare Market (2017-2032) by Application
9.2.1 Market Overview
9.2.2 Cancer
9.2.3 Respiratory Disease
9.2.4 Mobility Disorders
9.2.5 CVD & Hypertension
9.2.6 Pregnancy
9.2.7 Wound Care
9.2.8 Diabetes
9.2.9 Hearing Disorders
9.2.10 Others
9.3 North America Home Healthcare Market (2017-2032) by Country
9.3.1 United States of America
9.3.2 Canada
10 Europe Home Healthcare Market (2017-2032)
10.1 Europe Home Healthcare Market (2017-2032) by Product
10.1.1 Market Overview
10.1.2 Products
10.1.2.1 Therapeutic Products
10.1.2.1.1 Dialysis Equipment
10.1.2.1.2 Wound Care Products
10.1.2.1.3 IV Equipment
10.1.2.1.4 Sleep Apnea Therapeutic Devices
10.1.2.1.5 Insulin Delivery Devices
10.1.2.1.6 Oxygen Delivery Systems
10.1.2.1.7 Inhalers
10.1.2.1.8 Ventilators
10.1.2.1.9 Others
10.1.2.2 Diagnostic & Monitoring Products
10.1.2.2.1 Blood Glucose Monitors
10.1.2.2.2 Blood Pressure Monitors
10.1.2.2.3 Temperature Monitoring Device
10.1.2.2.4 Ovulation & Pregnancy Test Kits
10.1.2.2.5 Pulse Oximeters
10.1.2.2.6 Drug and Alcohol Test Kits
10.1.2.2.7 Home Sleep Testing Devices
10.1.2.2.8 Cholesterol Testing Products
10.1.2.2.9 ECG Devices
10.1.2.2.10 Home Hemoglobin A1C Test Kits
10.1.2.2.11 Others
10.1.2.3 Mobility Care Products
10.1.2.3.1 Wheelchair
10.1.2.3.2 Mobility Scooters
10.1.2.3.3 Walkers and Rollators
10.1.2.3.4 Crutches
10.1.2.3.5 Others
10.1.3 Services
10.1.3.1 Skilled Nursing Services
10.1.3.2 Rehabilitation Therapy Services
10.1.3.3 Hospice and Palliative Care Services
10.1.3.4 Respiratory Therapy Services
10.1.3.5 Infusion Therapy Services
10.1.3.6 Pregnancy Care Services
10.1.3.7 Others
10.2 Europe Home Healthcare Market (2017-2032) by Application
10.2.1 Market Overview
10.2.2 Cancer
10.2.3 Respiratory Disease
10.2.4 Mobility Disorders
10.2.5 CVD & Hypertension
10.2.6 Pregnancy
10.2.7 Wound Care
10.2.8 Diabetes
10.2.9 Hearing Disorders
10.2.10 Others
10.3 Europe Home Healthcare Market (2017-2032) by Country
10.3.1 United Kingdom
10.3.2 Germany
10.3.3 France
10.3.4 Italy
10.3.5 Others
11 Asia Pacific Home Healthcare Market (2017-2032)
11.1 Asia Pacific Home Healthcare Market (2017-2032) by Product
11.1.1 Market Overview
11.1.2 Products
11.1.2.1 Therapeutic Products
11.1.2.1.1 Dialysis Equipment
11.1.2.1.2 Wound Care Products
11.1.2.1.3 IV Equipment
11.1.2.1.4 Sleep Apnea Therapeutic Devices
11.1.2.1.5 Insulin Delivery Devices
11.1.2.1.6 Oxygen Delivery Systems
11.1.2.1.7 Inhalers
11.1.2.1.8 Ventilators
11.1.2.1.9 Others
11.1.2.2 Diagnostic & Monitoring Products
11.1.2.2.1 Blood Glucose Monitors
11.1.2.2.2 Blood Pressure Monitors
11.1.2.2.3 Temperature Monitoring Device
11.1.2.2.4 Ovulation & Pregnancy Test Kits
11.1.2.2.5 Pulse Oximeters
11.1.2.2.6 Drug and Alcohol Test Kits
11.1.2.2.7 Home Sleep Testing Devices
11.1.2.2.8 Cholesterol Testing Products
11.1.2.2.9 ECG Devices
11.1.2.2.10 Home Hemoglobin A1C Test Kits
11.1.2.2.11 Others
11.1.2.3 Mobility Care Products
11.1.2.3.1 Wheelchair
11.1.2.3.2 Mobility Scooters
11.1.2.3.3 Walkers and Rollators
11.1.2.3.4 Crutches
11.1.2.3.5 Others
11.1.3 Services
11.1.3.1 Skilled Nursing Services
11.1.3.2 Rehabilitation Therapy Services
11.1.3.3 Hospice and Palliative Care Services
11.1.3.4 Respiratory Therapy Services
11.1.3.5 Infusion Therapy Services
11.1.3.6 Pregnancy Care Services
11.1.3.7 Others
11.2 Asia Pacific Home Healthcare Market (2017-2032) by Application
11.2.1 Market Overview
11.2.2 Cancer
11.2.3 Respiratory Disease
11.2.4 Mobility Disorders
11.2.5 CVD & Hypertension
11.2.6 Pregnancy
11.2.7 Wound Care
11.2.8 Diabetes
11.2.9 Hearing Disorders
11.2.10 Others
11.3 Asia Pacific Home Healthcare Market (2017-2032) by Country
11.3.1 China
11.3.2 Japan
11.3.3 India
11.3.4 ASEAN
11.3.5 Australia
11.3.6 Others
12 Latin America Home Healthcare Market (2017-2032)
12.1 Latin America Home Healthcare Market (2017-2032) by Product
12.1.1 Market Overview
12.1.2 Products
12.1.2.1 Therapeutic Products
12.1.2.1.1 Dialysis Equipment
12.1.2.1.2 Wound Care Products
12.1.2.1.3 IV Equipment
12.1.2.1.4 Sleep Apnea Therapeutic Devices
12.1.2.1.5 Insulin Delivery Devices
12.1.2.1.6 Oxygen Delivery Systems
12.1.2.1.7 Inhalers
12.1.2.1.8 Ventilators
12.1.2.1.9 Others
12.1.2.2 Diagnostic & Monitoring Products
12.1.2.2.1 Blood Glucose Monitors
12.1.2.2.2 Blood Pressure Monitors
12.1.2.2.3 Temperature Monitoring Device
12.1.2.2.4 Ovulation & Pregnancy Test Kits
12.1.2.2.5 Pulse Oximeters
12.1.2.2.6 Drug and Alcohol Test Kits
12.1.2.2.7 Home Sleep Testing Devices
12.1.2.2.8 Cholesterol Testing Products
12.1.2.2.9 ECG Devices
12.1.2.2.10 Home Hemoglobin A1C Test Kits
12.1.2.2.11 Others
12.1.2.3 Mobility Care Products
12.1.2.3.1 Wheelchair
12.1.2.3.2 Mobility Scooters
12.1.2.3.3 Walkers and Rollators
12.1.2.3.4 Crutches
12.1.2.3.5 Others
12.1.3 Services
12.1.3.1 Skilled Nursing Services
12.1.3.2 Rehabilitation Therapy Services
12.1.3.3 Hospice and Palliative Care Services
12.1.3.4 Respiratory Therapy Services
12.1.3.5 Infusion Therapy Services
12.1.3.6 Pregnancy Care Services
12.1.3.7 Others
12.2 Latin America Home Healthcare Market (2017-2032) by Application
12.2.1 Market Overview
12.2.2 Cancer
12.2.3 Respiratory Disease
12.2.4 Mobility Disorders
12.2.5 CVD & Hypertension
12.2.6 Pregnancy
12.2.7 Wound Care
12.2.8 Diabetes
12.2.9 Hearing Disorders
12.2.10 Others
12.3 Latin America Home Healthcare Market (2017-2032) by Country
12.3.1 Brazil
12.3.2 Argentina
12.3.3 Mexico
12.3.4 Others
13 Middle East and Africa Home Healthcare Market (2017-2032)
13.1 Middle East and Africa Home Healthcare Market (2017-2032) by Product
13.1.1 Market Overview
13.1.2 Products
13.1.2.1 Therapeutic Products
13.1.2.1.1 Dialysis Equipment
13.1.2.1.2 Wound Care Products
13.1.2.1.3 IV Equipment
13.1.2.1.4 Sleep Apnea Therapeutic Devices
13.1.2.1.5 Insulin Delivery Devices
13.1.2.1.6 Oxygen Delivery Systems
13.1.2.1.7 Inhalers
13.1.2.1.8 Ventilators
13.1.2.1.9 Others
13.1.2.2 Diagnostic & Monitoring Products
13.1.2.2.1 Blood Glucose Monitors
13.1.2.2.2 Blood Pressure Monitors
13.1.2.2.3 Temperature Monitoring Device
13.1.2.2.4 Ovulation & Pregnancy Test Kits
13.1.2.2.5 Pulse Oximeters
13.1.2.2.6 Drug and Alcohol Test Kits
13.1.2.2.7 Home Sleep Testing Devices
13.1.2.2.8 Cholesterol Testing Products
13.1.2.2.9 ECG Devices
13.1.2.2.10 Home Hemoglobin A1C Test Kits
13.1.2.2.11 Others
13.1.2.3 Mobility Care Products
13.1.2.3.1 Wheelchair
13.1.2.3.2 Mobility Scooters
13.1.2.3.3 Walkers and Rollators
13.1.2.3.4 Crutches
13.1.2.3.5 Others
13.1.3 Services
13.1.3.1 Skilled Nursing Services
13.1.3.2 Rehabilitation Therapy Services
13.1.3.3 Hospice and Palliative Care Services
13.1.3.4 Respiratory Therapy Services
13.1.3.5 Infusion Therapy Services
13.1.3.6 Pregnancy Care Services
13.1.3.7 Others
13.2 Middle East and Africa Home Healthcare Market (2017-2032) by Application
13.2.1 Market Overview
13.2.2 Cancer
13.2.3 Respiratory Disease
13.2.4 Mobility Disorders
13.2.5 CVD & Hypertension
13.2.6 Pregnancy
13.2.7 Wound Care
13.2.8 Diabetes
13.2.9 Hearing Disorders
13.2.10 Others
13.3 Middle East and Africa Home Healthcare Market (2017-2032) by Country
13.3.1 Saudi Arabia
13.3.2 United Arab Emirates
13.3.3 Nigeria
13.3.4 South Africa
13.3.5 Others
14 Regulatory Framework
14.1 Regulatory Overview
14.2 US FDA
14.3 EU EMA
14.4 INDIA CDSCO
14.5 JAPAN PMDA
14.6 Others
15 Patent Analysis
15.1 Analysis by Type of Patent
15.2 Analysis by Publication Year
15.3 Analysis by Issuing Authority
15.4 Analysis by Patent Age
15.5 Analysis by CPC Analysis
15.6 Analysis by Patent Valuation
15.7 Analysis by Key Players
16 Strategic Initiatives
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership and Collaborations
16.3 Analysis by Joint Ventures
16.4 Analysis by Leading Players
16.5 Analysis by Geography
17 Supplier Landscape
17.1 Market Share Analysis, By Region (Top 5 Companies)
17.1.1 Market Share Analysis: Global
17.1.2 Market Share Analysis: North America
17.1.3 Market Share Analysis: Europe
17.1.4 Market Share Analysis: Asia-Pacific
17.1.5 Market Share Analysis: Others
17.2 Becton, Dickinson and Company
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Fresenius Medical Care
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 Medtronic plc
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 3M Company
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Abbott
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 B Braun Melsungen AG
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Arkray, Inc.
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 F Hoffmann La Roche AG
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 ConvaTech Group PLC
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 GE HealthCare
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Koninklijke Philips N.V.
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 ResMed, Inc.
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
18 Global Home Healthcare Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
**The supplier list is not exhaustive. Moreover, we can provide analysis of companies as per custom requests.
Datasheet
Single User License
Five User License
Corporate License
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.